Overview
- Provides a comprehensive treatment of pediatric drug development
- Highlights the anatomical, physiological and developmental differences between adults and children
- Draws a roadmap to better, innovative formulations, in particular for oral administration
- Includes supplementary material: sn.pub/extras
Part of the book series: AAPS Advances in the Pharmaceutical Sciences Series (AAPS, volume 11)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (30 chapters)
-
Compounding
-
Front Matter
-
-
Materials
-
Front Matter
-
-
Clinical Development and Regulatory Aspects
-
Front Matter
-
-
Concluding Remarks: The Future of Pediatric Formulations
-
Front Matter
-
-
Back Matter
Keywords
About this book
Reviews
From the reviews:
“This book can be useful not only for those in drug development, but also for pharmacists who work in pediatrics (either hospital or community pharmacists), compounding pharmacists, pediatricians, nurses who specialize in this area, and certainly students or residents in any of these disciplines who plan to focus on pediatrics. … I have reviewed and used many books on drug formulations and pharmaceutics, but I have not seen such a complete book devoted specifically to pediatrics.” (Patrick J. McDonnell, Doody’s Book Reviews, July, 2014)Editors and Affiliations
About the editors
Daniel Bar-Shalom is an Associate Professor in Drug Delivery at The Faculty of Health and Medical Sciences, University of Copenhagen. He has a degree in Biology from The Tel-Aviv University (1975), carried research in botany and then graduated from the School of Pharmacy, Hebrew University of Jerusalem (1982). He is a qualified pharmacist and has managed and owned a pharmacy in Haifa where he gained insight into the needs and idiosyncrasies of patients. He moved to Denmark in 1986 and founded Egalet, a drug delivery company where he served until 2007 as Vice President, R&D. He has been a consultant for various pharmaceutical and medical device companies. He is also the inventor of various technologies, holds many patents and has formulated marketed products. His main interests are controlled drug delivery and in particular oral pediatric formulations and geriatric formulations addressing the problem of polypharmacy.
Dr. Klaus Rose is CEO of Klausrose Consulting, Switzerland and advises on pediatric drug development and how to comply with FDA and EMA pediatric requirements. He has studied Latin languages, psychology and medicine. After postgraduate clinical training in general medicine in Germany and England, he joined the pharmaceutical industry. He has held various positions in R&D and medical affairs, was Global Head Pediatrics Novartis from 2001 to 2005 and was Global Head Pediatrics Roche from 2005 to 2009. After a year with a regulatory consultancy, he established his own business. Dr. Rose is a frequent speaker on international conferences on pediatric drug development, organizes trainings and publishes on a regular base.
Bibliographic Information
Book Title: Pediatric Formulations
Book Subtitle: A Roadmap
Editors: Daniel Bar-Shalom, Klaus Rose
Series Title: AAPS Advances in the Pharmaceutical Sciences Series
DOI: https://doi.org/10.1007/978-1-4899-8011-3
Publisher: Springer New York, NY
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: American Association of Pharmaceutical Scientists 2014
Hardcover ISBN: 978-1-4899-8010-6Published: 31 January 2014
Softcover ISBN: 978-1-4939-4521-4Published: 23 August 2016
eBook ISBN: 978-1-4899-8011-3Published: 30 January 2014
Series ISSN: 2210-7371
Series E-ISSN: 2210-738X
Edition Number: 1
Number of Pages: XV, 439
Number of Illustrations: 40 b/w illustrations, 36 illustrations in colour
Topics: Pharmaceutical Sciences/Technology, Pharmacy, Pediatrics
Industry Sectors: Biotechnology, Chemical Manufacturing, Consumer Packaged Goods, Pharma